Moreover, Nrf2 antibody could relieve DDP resistance mediated by TUG1 overexpression in ESCC cell, indicating an involvement of TUG1/Nrf2 signaling pathway in DDP resistance (Zhang Z. et al., 2019). Here, NFE2L2 is linked to esophageal squamous cell carcinoma.